South Africa Health

Basic health indicators in South Africa have improved recently thanks to surging government expenditure aimed at combating communicable diseases that have added to existing constraints in the public health system. The advent of universal health coverage under the National Health Insurance scheme in particular has created new opportunities in the sector, as well as offering the potential to reduce the economic impact of communicable diseases. Private sector participation will be critical to achieving long-term health care objectives, and a number of positive indicators – including rising investment in new facilities and strong growth within the pharmaceuticals industry – demonstrate the strong potential for continued sector growth.

This chapter contains an interview with Konji Sebati, CEO, Innovative Pharmaceutical Association South Africa.

The Report: South Africa 2016

The Report

This chapter is from the South Africa 2016 report. Explore other chapters from this report.

Interviews & Viewpoints

Sketch of Konji Sebati, CEO, Innovative Pharmaceutical Association South Africa (IPASA) 
Konji Sebati, CEO, Innovative Pharmaceutical Association South Africa (IPASA): Interview

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart